151 related articles for article (PubMed ID: 23570823)
1. The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis.
Azadeh N; Chang YH; Kusne S; Vikram HR; Seville MT; Orenstein R; Blair JE
J Infect; 2013 Aug; 67(2):148-55. PubMed ID: 23570823
[TBL] [Abstract][Full Text] [Related]
2. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis.
Ampel NM; Giblin A; Mourani JP; Galgiani JN
Clin Infect Dis; 2009 Jan; 48(2):172-8. PubMed ID: 19072555
[TBL] [Abstract][Full Text] [Related]
3. Wheezes and desert breezes: when asthma and valley fever collide.
Azadeh N; Rank MA; Lewis JC; Wesselius LJ; Cheng MR; Blair JE
J Asthma; 2016; 53(2):125-32. PubMed ID: 26312545
[TBL] [Abstract][Full Text] [Related]
4. Surgical pathology of pleural coccidioidomycosis: a clinicopathological study of 36 cases.
Shekhel TA; Ricciotti RW; Blair JE; Colby TV; Sobonya RE; Larsen BT
Hum Pathol; 2014 May; 45(5):961-9. PubMed ID: 24613568
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary coccidioidomycosis.
Spinello IM; Munoz A; Johnson RH
Semin Respir Crit Care Med; 2008 Apr; 29(2):166-73. PubMed ID: 18365998
[TBL] [Abstract][Full Text] [Related]
6. Coccidioidomycosis of the male genital tract.
Sohail MR; Andrews PE; Blair JE
J Urol; 2005 Jun; 173(6):1978-82. PubMed ID: 15879796
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis.
Thompson GR; Blair JE; Wang S; Bercovitch R; Bolaris M; Van Den Akker D; Lopez R; Heidari A; Catanzaro A; Cadena J; Chin-Hong P; Spellberg B; Johnson R
Clin Infect Dis; 2017 Jul; 65(2):338-341. PubMed ID: 28419259
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion.
Fardet L; Flahault A; Kettaneh A; Tiev KP; Généreau T; Tolédano C; Lebbé C; Cabane J
Br J Dermatol; 2007 Jul; 157(1):142-8. PubMed ID: 17501951
[TBL] [Abstract][Full Text] [Related]
9. Video-assisted thoracoscopic surgery for patients with pulmonary coccidioidomycosis.
Ashfaq A; Vikram HR; Blair JE; Jaroszewski DE
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1217-23. PubMed ID: 24602514
[TBL] [Abstract][Full Text] [Related]
10. Sweet syndrome (acute febrile neutrophilic dermatosis) associated with pulmonary coccidioidomycosis.
DiCaudo DJ; Ortiz KJ; Mengden SJ; Lim KK
Arch Dermatol; 2005 Jul; 141(7):881-4. PubMed ID: 16027305
[TBL] [Abstract][Full Text] [Related]
11. Disseminated cutaneous coccidioidomycosis masquerading as lupus pernio.
Newlon HR; Lambiase MC
Cutis; 2010 Jul; 86(1):25-8. PubMed ID: 21049763
[TBL] [Abstract][Full Text] [Related]
12. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis.
Catanzaro A; Cloud GA; Stevens DA; Levine BE; Williams PL; Johnson RH; Rendon A; Mirels LF; Lutz JE; Holloway M; Galgiani JN
Clin Infect Dis; 2007 Sep; 45(5):562-8. PubMed ID: 17682989
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E
Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262
[TBL] [Abstract][Full Text] [Related]
14. Coccidioidomycosis in patients with hematologic malignancies.
Blair JE; Smilack JD; Caples SM
Arch Intern Med; 2005 Jan; 165(1):113-7. PubMed ID: 15642886
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral corticosteroids on chronic warfarin therapy.
Hazlewood KA; Fugate SE; Harrison DL
Ann Pharmacother; 2006 Dec; 40(12):2101-6. PubMed ID: 17119104
[TBL] [Abstract][Full Text] [Related]
16. Does the presence of mediastinal adenopathy confer a risk for disseminated infection in immunocompetent persons with pulmonary coccidioidomycosis?
Mayer AP; Morris MF; Panse PM; Ko MG; Files JA; Ruddy BE; Blair JE
Mycoses; 2013 Mar; 56(2):145-9. PubMed ID: 22809175
[TBL] [Abstract][Full Text] [Related]
17. Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs.
Taroumian S; Knowles SL; Lisse JR; Yanes J; Ampel NM; Vaz A; Galgiani JN; Hoover SE
Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1903-9. PubMed ID: 22745051
[TBL] [Abstract][Full Text] [Related]
18. Coccidioidomycosis in elderly persons.
Blair JE; Mayer AP; Currier J; Files JA; Wu Q
Clin Infect Dis; 2008 Dec; 47(12):1513-8. PubMed ID: 18990061
[TBL] [Abstract][Full Text] [Related]
19. Outcomes among inmates treated for coccidioidomycosis at a correctional institution during a community outbreak, Kern County, California, 2004.
Burwell LA; Park BJ; Wannemuehler KA; Kendig N; Pelton J; Chaput E; Jinadu BA; Emery K; Chavez G; Fridkin SK
Clin Infect Dis; 2009 Dec; 49(11):e113-9. PubMed ID: 19886797
[TBL] [Abstract][Full Text] [Related]
20. Oral health in patients on inhaled corticosteroid treatment.
Komerik N; Akkaya A; Yildiz M; Buyukkaplan US; Kuru L
Oral Dis; 2005 Sep; 11(5):303-8. PubMed ID: 16120117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
